{"schema_version":"secwatch.filing_event.v1","accession":"0000021076-25-000010","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.892307+00:00","generated_at":"2026-05-27T04:13:50.010840+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Clorox Q2 net sales down 15%; Glad JV to wind down; adjusted EPS falls 28%","bullets":["Net sales fell 15% to $1.69B; organic sales down 9%; diluted EPS $1.54 (+105%) but adjusted EPS $1.55 (-28% YoY).","Gross margin improved 30 bps to 43.8% on cost savings, partially offset by lower cost absorption and higher manufacturing costs.","Clorox and P&G wind down Glad jt venture by Jan 31, 2026; Clorox to acquire P&G’s 20% interest.","YTD operating cash flow $401M (+132% YoY); free cash flow $309M (9.0% of sales)."],"urls":{"canonical":"https://secwatch.observer/filing/0000021076-25-000010","json":"https://secwatch.observer/filing/0000021076-25-000010.json","markdown":"https://secwatch.observer/filing/0000021076-25-000010.md","text":"https://secwatch.observer/filing/0000021076-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000002107625000010/0000021076-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000002107625000010/clx-20250203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T04:13:50.010840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}